Quan Anh Vu
CIK: 0001892297
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Monopar Therapeutics
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 30, 2026MNPR
Monopar Therapeutics
Exercise(M)Direct614 shares- - Sep 30, 2026MNPR
Monopar Therapeutics
Tax Payment(F)Direct180 shares at avg. $79.67$14K - Jun 30, 2026MNPR
Monopar Therapeutics
Tax Payment(F)Direct507 shares at avg. $92.59$47K - Jun 30, 2026MNPR
Monopar Therapeutics
Exercise(M)Direct1.2K shares- - Dec 26, 2025MNPR
Monopar Therapeutics
Purchase(P)Direct1.5K shares at avg. $69.95$105K - Dec 2, 2025MNPR
Monopar Therapeutics
Award(A)DirectStock Options
7.1K shares- - Dec 2, 2025MNPR
Monopar Therapeutics
Award(A)DirectRestricted Stock Units
9.8K shares- - Mar 3, 2025MNPR
Monopar Therapeutics
Award(A)DirectStock Options
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | MNPR Monopar Therapeutics | Exercise(M) | 614 | - | $0 | Direct |
| Sep 30, 2026 | MNPR Monopar Therapeutics | Tax Payment(F) | 180 | $79.67 | $14,341 | Direct |
| Jun 30, 2026 | MNPR Monopar Therapeutics | Tax Payment(F) | 507 | $92.59 | $46,943 | Direct |
| Jun 30, 2026 | MNPR Monopar Therapeutics | Exercise(M) | 1,228 | - | $0 | Direct |
| Dec 26, 2025 | MNPR Monopar Therapeutics | Purchase(P) | 1,500 | $69.95 | $104,925 | Direct |
| Dec 2, 2025 | MNPR Monopar Therapeutics | Award(A) Stock Options | 7,135 | - | - | Direct |
| Dec 2, 2025 | MNPR Monopar Therapeutics | Award(A) Restricted Stock Units | 9,826 | - | - | Direct |
| Mar 3, 2025 | MNPR Monopar Therapeutics | Award(A) Stock Options | 25,000 | - | - | Direct |
1-8 of 8 transactions
About Vu Quan Anh
Vu Quan Anh (SEC CIK 0001892297) files insider reports with the SEC as Chief Financial Officer of Monopar Therapeutics (MNPR).
Signal8 holds 6 ownership filings by Vu Quan Anh (1 Form 3, 5 Form 4), filed between Mar 5, 2025 and Oct 2, 2026. Those filings report 8 transactions, from Mar 3, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vu Quan Anh's filings is in WILMETTE, IL.
Recent filings by Vu Quan Anh
- Sep 30, 2026: Option exercise of MNPR shares (Form 4, code M).
- Sep 30, 2026: Tax withholding of MNPR shares (Form 4, code F).
- Jun 30, 2026: Tax withholding of MNPR shares (Form 4, code F).
- Jun 30, 2026: Option exercise of MNPR shares (Form 4, code M).
- Dec 26, 2025: Open-market purchase of MNPR shares (Form 4, code P).
Other insiders filing for Monopar Therapeutics (MNPR)
- Robinson Chandler, Chief Executive Officer
- STARR CHRISTOPHER M, Director
- Cittadine Andrew, Chief Operating Officer
- Tsuchimoto Kim R, Director
- Anderson Raymond, Director
- RIOUX PATRICE, Officer